Bhardwaj Apurva, Bahl Charu, Sharma Siddharth, Singh Navneet, Behera Digamber
Department of Biotechnology, Thapar University, Patiala, Punjab-147002, India.
Department of Biotechnology, Thapar University, Patiala, Punjab-147002, India.
Mutat Res Genet Toxicol Environ Mutagen. 2018 Feb;826:15-24. doi: 10.1016/j.mrgentox.2017.12.006. Epub 2017 Dec 21.
Cancer, a multi-step, multifactorial and multi-gene disease, not only damages the genomic integrity of the cell but also hinders the DNA repair mechanisms of the body. Gene-gene and gene environment interactions amongst the genetic polymorphisms together modulate the susceptibility towards a cancer. We have studied the high order gene interactions between the genetic polymorphism of detoxifying genes (CYP1A1, Ahr, XRCC and GST1) that play a key role in the metabolism of the xenobiotics and have been proved to be prognostic markers for lung cancer METHODS: 237 cases and 250 controls have been genotyped using PCR-RFLP technique. In order to find out the association, unconditional logistic regression approach was used and to analyse high order interactions MDR and CART was used.
In the MDR analysis, the best model was one factor model which included GSTM1 (CVC 10/10, Prediction error = 0.43, p < .001). The best three factor model comprised of XRCC1 632, XRCC1 206, GSTM1 (CVC 10/10, Prediction error = 0.45, p < .0001). The CART analysis exhibited that Node 1 carrying mutant type of GSTM1 imposed the highest risk towards lung cancer (OR = 11.0, 95%C.I. = 6.05-20.03, p = .000001). Wild type of GSTM1 when combined with mutant type of CYP1A1 M2 and XRCC1 632, an 8 fold risk towards lung cancer was observed (95%C.I. = 4.07-16.29, p = .00001). The high order interactions were used to predict the prognosis of lung cancer patients. Of all the genetic variants, XRCC1 632, GSTM1 and AhR rs2066853 was the most important determinant of overall survival of lung cancer patients CONCLUSION: Through the study we introduced the concept of polygenic approach to get an insight about the various polymorphic variants in determining cancer susceptibility. Lesser number of subjects were found in the high risk subgroups. Further studies with larger sample size are required to warranty the above findings.
癌症是一种多步骤、多因素和多基因疾病,不仅会破坏细胞的基因组完整性,还会阻碍机体的DNA修复机制。基因多态性之间的基因-基因和基因-环境相互作用共同调节对癌症的易感性。我们研究了在异生物代谢中起关键作用且已被证明是肺癌预后标志物的解毒基因(CYP1A1、Ahr、XRCC和GST1)基因多态性之间的高阶基因相互作用。方法:采用PCR-RFLP技术对237例病例和250例对照进行基因分型。为了找出关联,使用了无条件逻辑回归方法,并使用MDR和CART分析高阶相互作用。
在MDR分析中,最佳模型是单因素模型,包括GSTM1(交叉验证一致性10/10,预测误差=0.43,p<0.001)。最佳三因素模型由XRCC1 632、XRCC1 206、GSTM1组成(交叉验证一致性10/10,预测误差=0.45,p<0.0001)。CART分析显示,携带GSTM1突变型的节点1对肺癌的风险最高(比值比=11.0,95%置信区间=6.05-20.03,p=0.000001)。当GSTM1野生型与CYP1A1 M2和XRCC1 632突变型结合时,观察到患肺癌的风险增加8倍(95%置信区间=4.07-16.29,p=0.00001)。高阶相互作用用于预测肺癌患者的预后。在所有基因变异中,XRCC1 632、GSTM1和AhR rs2066853是肺癌患者总生存的最重要决定因素。结论:通过本研究,我们引入了多基因方法的概念,以深入了解各种多态性变异在确定癌症易感性方面的作用。在高风险亚组中发现的受试者数量较少。需要进行更大样本量的进一步研究来证实上述发现。